Prevalence of Substandard and Falsified Essential Medicines: Still an Incomplete Picture

JAMA Netw Open. 2018 Aug 3;1(4):e181685. doi: 10.1001/jamanetworkopen.2018.1685.

Author

Tim K Mackey^{1

2

3}

Affiliations

¹ Division of Infectious Diseases and Global Public Health, Department of Anesthesiology, School of Medicine, University of California, San Diego.
² Global Health Policy Institute, San Diego, California.
³ World Health Organization Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector, University of Toronto, Toronto, Ontario, Canada.

PMID: 30646099
DOI: 10.1001/jamanetworkopen.2018.1685

No abstract available

Publication types

Comment

MeSH terms

Cost of Illness
Counterfeit Drugs*
Drugs, Essential*
Income
Prevalence

Substances

Counterfeit Drugs
Drugs, Essential